Endologix Inc. To Report Fourth Quarter And Full Year 2013 Financial Results On February 27, 2014
IRVINE, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2013 financial results, which will take place on Thursday, February 27, 2014 after the close of the market.
Help employers find you! Check out all the jobs and post your resume.